April 4, 2022 –  Esperion presented two new analyses from its clinical development program of bempedoic acid (NEXLETOL) at the American College of Cardiology’s 71st Annual Scientific Session & Expo (ACC.22).

April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence solutions to help hospitals identify and manage their most at-risk cardiac patients, today

April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath, according to late-breaking research presented today at the American College of Cardiology (ACC) Scientific Session in Washington, D.C.

April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today presented detailed results from its phase 1 APOLLO trial that showed SLN360, an investigational siRNA, reduced

April 2, 2022 — Aidoc, a leading provider of healthcare AI solutions, announced that it received FDA 510(k) clearance for its triage and notification of pneumothorax on X-ray exams. A one-stop partner for the enterprise’s clinical AI needs, Aidoc’s other seven FDA-cleared solutions are already implemented across U.S.

April 2, 2022 —  Royal Philips, a global leader in health technology, today announced the launch of 

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America, increases the focus on preventing heart failure (HF) in people who are showing early signs of “pre-heart failure,” and updates treatment strategies for people with symptomatic heart failure to include

April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of atherosclerosis, the pathological process underlying cardiovascular conditions such as myocardial infarction and stroke. A study carried out by scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and led by cardiologists Valentín Fuster and Borja Ibáñez suggests that the bone marrow is activated in response to known cardiovascular risk factors.

April 1, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, has announced that Poland’s National Institute of Cardiology, the leading clinical center of cardiology and car

April 1, 2022 – Over the course of the pandemic, a number of studies examined whether COVID-19 patients were at increased risk for stroke, with variable results. Most studies, however, lumped all stroke patients together, rather than separating the less vs. more severe cases.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now